First Header Logo Second Header Logo

Connection

Ashish Khanna to Depressive Disorder, Major

This is a "connection" page, showing publications Ashish Khanna has written about Depressive Disorder, Major.
Connection Strength

0.358
  1. Szczepanik J, Nugent AC, Drevets WC, Khanna A, Zarate CA, Furey ML. Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder. Psychiatry Res Neuroimaging. 2016 Aug 30; 254:67-73.
    View in: PubMed
    Score: 0.138
  2. Furey ML, Drevets WC, Szczepanik J, Khanna A, Nugent A, Zarate CA. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine. Int J Neuropsychopharmacol. 2015 Mar 28; 18(8).
    View in: PubMed
    Score: 0.127
  3. Furey ML, Khanna A, Hoffman EM, Drevets WC. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology. 2010 Nov; 35(12):2479-88.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.